Your browser is no longer supported. Please, upgrade your browser.
SONN Sonnet BioTherapeutics Holdings, Inc. daily Stock Chart
Sonnet BioTherapeutics Holdings, Inc.
Index- P/E- EPS (ttm)-54.99 Insider Own7.60% Shs Outstand11.91M Perf Week-19.53%
Market Cap32.40M Forward P/E- EPS next Y-0.93 Insider Trans0.00% Shs Float8.51M Perf Month-17.33%
Income-17.20M PEG- EPS next Q- Inst Own0.50% Short Float6.54% Perf Quarter-36.74%
Sales28.00M P/S1.16 EPS this Y-23.90% Inst Trans415.58% Short Ratio0.20 Perf Half Y-81.32%
Book/sh-8.73 P/B- EPS next Y- ROA- Target Price- Perf Year-85.69%
Cash/sh0.04 P/C64.79 EPS next 5Y- ROE- 52W Range2.52 - 54.60 Perf YTD-82.27%
Dividend- P/FCF- EPS past 5Y22.30% ROI-436.50% 52W High-95.02% Beta1.05
Dividend %- Quick Ratio0.10 Sales past 5Y0.20% Gross Margin6.80% 52W Low7.94% ATR0.49
Employees587 Current Ratio0.10 Sales Q/Q-26.90% Oper. Margin- RSI (14)39.99 Volatility7.69% 15.35%
OptionableNo Debt/Eq- EPS Q/Q67.70% Profit Margin- Rel Volume0.32 Prev Close2.64
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.78M Price2.72
Recom2.00 SMA20-13.84% SMA50-22.90% SMA200-74.31% Volume882,982 Change3.03%
Aug-04-20 07:35AM  
Jul-20-20 07:30AM  
Jul-15-20 07:30AM  
May-18-20 07:30AM  
Apr-06-20 07:30AM  
SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.